The value of screening tests in children with neurofibromatosis type 1 (NF1)
Crossref DOI link: https://doi.org/10.1007/s00381-020-04711-6
Published Online: 2020-06-10
Published Print: 2020-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Baudou, Eloïse http://orcid.org/0000-0003-3659-5766
Chaix, Yves
Text and Data Mining valid from 2020-06-10
Version of Record valid from 2020-06-10
Article History
Received: 16 May 2020
Accepted: 28 May 2020
First Online: 10 June 2020
Compliance with ethical standards
:
: No conflict